Capital Institute For Neurosciences Center For Neuro-Oncology - Pennington, New Jersey 08534

Capital Institute For Neurosciences Center For Neuro-Oncology is categorized under Health Services in Pennington, NJ .

Business Name: Capital Institute For Neurosciences Center For Neuro-Oncology
Address: 2 Capital Way # 456, Pennington, New Jersey 08534
Phone Number: (609) 537-7300
Annual Revenue (USD): $100.000 to $499.999
Founding Year: 2012
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Health Services
SIC Code: 8099
NAICS Code: 621999
Share This Business:
Related Businesses: Dermalink Healthcare LLC - Pennington, NJ 08534
New Jersey Health Care Quality - Pennington, NJ 08534
Pediatrix Medical Group - Pennington, NJ 08534
Mercer County Medical Society - Pennington, NJ 08534
Mercer Laboratory-Pennington - Pennington, NJ 08534
American Health Enter - Pennington, NJ 08534
Hunterdon Healthcare Syst - Pennington, NJ 08534
Medical Claims Relief LLC - Pennington, NJ 08534
Suzuki Medical Assoc-Penningtn - Pennington, NJ 08534
Medic International Usa LLC - Pennington, NJ 08534

The company Capital Institute For Neurosciences Center For Neuro-Oncology provides B2C services in the form of Health Services from its single location in New Jersey. 1 to 4 employees work for Capital Institute For Neurosciences Center For Neuro-Oncology, and the business now earns $100.000 to $499.999 per annum.

Capital Institute For Neurosciences Center For Neuro-Oncology was launched in 2012 and is classified under SIC code and category 8099 , and NAICS number and grouping 621999 . To contact Capital Institute For Neurosciences Center For Neuro-Oncology, please call with the phone number (609) 537-7300 or visit its single location at 2 Capital Way # 456 in Pennington, New Jersey 08534.

The location of the single location can also be found using the coordinates 40.3199,-74.7876. Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.